An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Gossamer Bio, Inc. (NASDAQ: GOSS) has scheduled a conference call and webcast for investors on October 11, 2021 at 2:30 pm ET. The event will focus on the company's new clinical product candidates in immunology, inflammation, and oncology. Management will provide insights into their pipeline and will be available for questions.
Investors can access the live webcast on Gossamer's website or dial in using the provided numbers. A replay will be available for 30 days.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will host a conference call and webcast for investors and analysts on Monday, October 11, 2021, at 2:30 pm ET to announce its next clinical product candidates.
Gossamer management will present and discuss its forthcoming additions to its clinical product candidate pipeline. As part of the event, Gossamer Bio management will be available for questions.
Conference Call and Webcast
Gossamer will host a conference call and live audio webcast at 2:30 pm ET on Monday, October 11. The live audio webcast may be accessed through the “Events / Presentations” page in the “Investors” section of the Company's website at www.gossamerbio.com. Alternatively, the conference call may be accessed through the following:
A replay of the audio webcast will be available for 30 days on the “Investors” section of the Company's website, www.gossamerbio.com.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
For Investors and Media:
Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
Gossamer Bio Investor Relations
ir@gossamerbio.com
Source: Gossamer Bio, Inc.
FAQ
What is the date and time of Gossamer Bio's conference call and webcast?
Gossamer Bio's conference call and webcast is scheduled for October 11, 2021, at 2:30 pm ET.
How can I access the conference call for Gossamer Bio?
You can access the conference call by dialing (833) 646-0603 for domestic calls or (929) 517-9782 for international calls. The conference ID is 4165598.
Where can I find the webcast for Gossamer Bio's investor conference?
The live audio webcast can be accessed through the 'Events / Presentations' page in the 'Investors' section of Gossamer Bio's website.
Will there be a replay available for Gossamer Bio's conference call?
Yes, a replay of the audio webcast will be available for 30 days on Gossamer Bio's website.
What topics will Gossamer Bio discuss during the conference call?
Gossamer Bio will discuss its forthcoming additions to its clinical product candidate pipeline.
